Viewing Study NCT06547528


Ignite Creation Date: 2025-12-26 @ 11:14 AM
Ignite Modification Date: 2026-01-13 @ 9:27 AM
Study NCT ID: NCT06547528
Status: RECRUITING
Last Update Posted: 2025-06-03
First Post: 2024-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL
Sponsor: Ono Pharmaceutical Co. Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module